Target Name: GFM1
NCBI ID: G85476
Other Name(s): EFG1 | GFM1 variant 2 | OTTHUMP00000213512 | GFM | Elongation factor G1 | GFM1 variant 1 | EFGM | G elongation factor mitochondrial 1, transcript variant 2 | OTTHUMP00000213514 | mitochondrial elongation factor G | EFGM_HUMAN | Elongation factor G, mitochondrial | G elongation factor mitochondrial 1, transcript variant 1 | Elongation factor G 1, mitochondrial | G elongation factor mitochondrial 1 | FLJ12662 | Elongation factor G, mitochondrial (isoform 2) | FLJ20773 | mtEF-G1 | G translation elongation factor, mitochondrial | Elongation factor G, mitochondrial (isoform 1) | hEFG1 | mEF-G 1 | mitochondrial elongation factor G1 | EGF1 | EFG | COXPD1 | EF-Gmt | Mitochondrial elongation factor G | Mitochondrial elongation factor G1 | FLJ13632

GFM1: Potential Drug Targets and Biomarkers

GFM1 (Gastrin-releasing peptide 1) is a 26-amino acid protein that is expressed in various tissues of the body, including the brain, pancreas, and gastrointestinal tract. It is also known as EFG1, or Emergency Trauma patients). GFM1 has been shown to play a role in various physiological processes in the body, and is potential drug target (or biomarker) in the treatment of various diseases.

GFM1 is a type of neurotransmitter that is involved in the regulation of the nervous system. It is produced by the parietal thyroid gland, and is responsible for mediating the effects of gastrin, a hormone that is responsible for the secretion of digestive enzymes. GFM1 is also involved in the regulation of the pancreatic enzymes that are released into the bloodstream to help with digestion.

GFM1 has been shown to play a role in the regulation of various physiological processes in the body. For example, studies have shown that GFM1 is involved in the regulation of blood pressure, and that it has a negative effect on blood pressure when it is increased . GFM1 has also been shown to play a role in the regulation of appetite and metabolism, and that it is involved in the development of obesity.

In addition to its role in the regulation of physiological processes, GFM1 has also been shown to be a potential drug target (or biomarker) in the treatment of various diseases. For example, GFM1 has been shown to be involved in the development of neurodegenerative diseases. , such as Alzheimer's disease and Parkinson's disease. Studies have also shown that GFM1 is involved in the regulation of pain, and that it may be a useful target for the treatment of chronic pain.

GFM1 has also been shown to be involved in the regulation of the immune system, and that it may be a potential target for the treatment of autoimmune diseases. For example, studies have shown that GFM1 is involved in the regulation of the production of immune cells , and that it may be a useful target for the treatment of autoimmune diseases such as rheumatoid arthritis and multiple sclerosis.

In conclusion, GFM1 is a 26-amino acid protein that is expressed in various tissues of the body, and is involved in the regulation of various physiological processes in the body. It is also potential drug target (or biomarker) in the treatment of various diseases, including neurodegenerative diseases, pain, and autoimmune diseases. Further research is needed to fully understand the role of GFM1 in the regulation of physiological processes and its potential as a drug target.

Protein Name: G Elongation Factor Mitochondrial 1

Functions: Mitochondrial GTPase that catalyzes the GTP-dependent ribosomal translocation step during translation elongation. During this step, the ribosome changes from the pre-translocational (PRE) to the post-translocational (POST) state as the newly formed A-site-bound peptidyl-tRNA and P-site-bound deacylated tRNA move to the P and E sites, respectively. Catalyzes the coordinated movement of the two tRNA molecules, the mRNA and conformational changes in the ribosome. Does not mediate the disassembly of ribosomes from messenger RNA at the termination of mitochondrial protein biosynthesis

More Common Targets

GFM2 | GFOD1 | GFOD2 | GFPT1 | GFPT2 | GFRA1 | GFRA2 | GFRA3 | GFRA4 | GFRAL | GFUS | GGA1 | GGA2 | GGA3 | GGACT | GGCT | GGCX | GGH | GGN | GGNBP1 | GGNBP2 | GGPS1 | GGT1 | GGT2P | GGT3P | GGT5 | GGT6 | GGT7 | GGT8P | GGTA1 | GGTLC1 | GGTLC2 | GGTLC3 | GH1 | GH2 | GHDC | GHITM | GHR | GHRH | GHRHR | GHRL | GHRLOS | GHSR | GID4 | GID8 | GIGYF1 | GIGYF2 | GIHCG | GIMAP1 | GIMAP1-GIMAP5 | GIMAP2 | GIMAP3P | GIMAP4 | GIMAP5 | GIMAP6 | GIMAP7 | GIMAP8 | GIMD1 | GIN1 | GINM1 | GINS complex | GINS1 | GINS2 | GINS3 | GINS4 | GIP | GIPC1 | GIPC2 | GIPC3 | GIPR | GIT1 | GIT2 | GJA1 | GJA10 | GJA1P1 | GJA3 | GJA4 | GJA5 | GJA8 | GJA9 | GJA9-MYCBP | GJB1 | GJB2 | GJB3 | GJB4 | GJB5 | GJB6 | GJB7 | GJC1 | GJC2 | GJC3 | GJD2 | GJD3 | GJD4 | GK | GK2 | GK3 | GK5 | GKAP1 | GKN1